Immunogenicity and safety of Cervarix HPV-16/18 AS04-adjuvant vaccine against HPV induced cervical cancer in women (15+ years). (2024). UCC Student Medical Journal, 3, 50-61. https://doi.org/10.33178/SMJ.2023.1.5